Edinburgh-based Craneware, a provider of software for the US healthcare market, said on Monday its revenue increased 6% to $38 million in the six months to December 31 and profit before tax increased 3% to $9.9 million.

Interim dividend increased 4% to 12p per share.

Craneware CEO Keith Neilson said: “The positive performance in the first half of the year provides a strong foundation for future growth.

“We are making considerable progress on our Trisus expansion strategy and seeing accelerated adoption of this cloud-platform by our existing and new customers.

“Managing the impact of the COVID-19 pandemic has clearly been the top priority for all healthcare-related organisations over the past year and will continue to be the case for many months to come, providing front-line care while adjusting to new methods of healthcare delivery and ensuring their financial operations can respond.

“Our customers continue to take steps to create further resilience across their financial operations and we are committed to providing them with the tools and insight to do so.

“The first half’s positive sales performance has continued with ongoing pipeline growth, a growing Trisus customer base, expanding offering and clear market need.

“While cognisant of the challenges presented by the macro environment, we are confident in the continued positive performance of the business and accelerated growth rates moving forward.”